Anebulo Pharmaceuticals (ANEB) Institutional Ownership → A new way to collect income from stocks (From DTI) (Ad) Free ANEB Stock Alerts $3.00 +0.04 (+1.35%) (As of 04/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)CurrentInstitutional OwnershipPercentage28.40%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$696.73KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$70.89K Get ANEB Insider Trade Alerts Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANEB Institutional Buying and Selling by Quarter Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Anebulo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.153,003$370K0.0%+584.8%0.597% 2/15/2024Vanguard Group Inc.153,003$370K0.0%+584.8%0.597% 1/16/2024LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509% 12/18/2023Vanguard Group Inc.22,344$68K0.0%+39.4%0.087% 11/14/2023Tower Research Capital LLC TRC 20,851$64K0.0%+241.8%0.081% 2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116% 11/10/2022Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994% 10/14/2022LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888% 7/22/2022LVW Advisors LLC700,000$3.64M0.7%N/A2.999% 8/18/2021Ikarian Capital LLC174,811$1.20M0.1%N/A0.749% 8/17/202122NW LP3,343,565$22.80M6.1%N/A14.322% 8/17/2021Boothbay Fund Management LLC19,835$135K0.0%N/A0.085% 8/13/2021Laurion Capital Management LP225,000$1.55M0.0%N/A0.964% (Data available from 1/1/2016 forward) ANEB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANEB shares? During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: LVW Advisors LLC ($1.56M), Nantahala Capital Management LLC ($1.43M), Vanguard Group Inc. ($370K), and Herr Investment Group LLC ($72K), Tower Research Capital LLC TRC ($64K).Learn more on ANEB's institutional investors. What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors? 28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings. Which institutional investors have been buying Anebulo Pharmaceuticals stock? The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($700K), Nantahala Capital Management LLC ($511.07K), Vanguard Group Inc. ($267.63K), Herr Investment Group LLC ($29.64K), and Tower Research Capital LLC TRC ($14.75K). How much institutional buying is happening at Anebulo Pharmaceuticals? Institutional investors have bought a total of 1,523,097 shares in the last 24 months. This purchase volume represents approximately $5.84M in transactions. Which Anebulo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($54.33K). How much institutional selling is happening at Anebulo Pharmaceuticals? Institutional investors have sold a total of 54,328 shares in the last 24 months. This volume of shares sold represents approximately $140.99K in transactions. Related Companies: Equillium Major Shareholders Kronos Bio Major Shareholders Landos Biopharma Major Shareholders MediciNova Major Shareholders Checkpoint Therapeutics Major Shareholders Eagle Pharmaceuticals Major Shareholders Immuneering Major Shareholders Eliem Therapeutics Major Shareholders Immix Biopharma Major Shareholders vTv Therapeutics Major Shareholders This page (NASDAQ:ANEB) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.